The DOI matches its Crossref record; 104 of the 106 references it cites were found in a registry or an index.
Clinical management of adrenocortical carcinoma
Abstract
Adrenocortical carcinoma (ACC) is a rare and heterogeneous malignancy, and most of the diagnostic and therapeutic strategies are not fully established according to criteria of evidence-based medicine. However, recently collaborative efforts (e.g. International Consensus Conference 2003 and networks like the European Network for the Study of Adrenal Tumours (ENSAT)) have significantly advanced the field. This article summarizes current standards in the management of ACC. In patients with suspected ACC a thorough endocrine and imaging work-up is followed by complete (Ro) resection of the tumour by an expert surgeon and initiation of adjuvant mitotane. In advanced disease not amenable to radical resection, cytotoxic drugs will be added to mitotane. The most promising regimens (etoposide, doxorubicin, cisplatin plus mitotane and streptozotocin plus mitotane) are currently compared in an international phase-III trial. Several targeted therapies are under investigation (e.g. IGF-1 inhibitors, sunitinib, sorafenib) and may lead to new treatment options.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The median age of diagnosis is in the fifth to sixth decade, with the German ACC Registry reporting a median age at diagnosis of 46 years (9).”
From Adrenocortical carcinoma (2014) · cites this paper as [9]
In the citing paper
“Another third present with nonspecific symptoms due to local tumor growth, such as abdominal or flank pain, abdominal fullness, or early satiety (9, 10).”
From Adrenocortical carcinoma (2014) · cites this paper as [9]
In the citing paper
“For 40% to 60% of patients, the major presenting complaints are symptoms and signs of hormone excess (3, 9, 10).”
From Adrenocortical carcinoma (2014) · cites this paper as [9]
In the citing paper
“Biochemically or clinically apparent adrenocortical hormone production is evident in up to 45% to 70% (9, 10, 85).”
From Adrenocortical carcinoma (2014) · cites this paper as [9]
In the citing paper
“At the time of presentation, ACCs are generally large tumors, measuring on average 10 to 13 cm (9, 85, 89).”
From Adrenocortical carcinoma (2014) · cites this paper as [9]
In the citing paper
“Hypercortisolism is the most common presentation of patients presenting with hormone excess (50%–80% of hormone-secreting ACCs), causing classic symptoms including plethora, diabetes mellitus, muscle weakness/atrophy, and osteoporosis.”
From Adrenocortical carcinoma (2014) · cites this paper as [9]
In the citing paper
“Although earlier studies found 49% of patients with metastatic disease (stage 4) at presentation, currently only 25% to 30% of patients present with metastatic disease (9, 13, 25).”
From Adrenocortical carcinoma (2014) · cites this paper as [9]
Citations
Cites
Management of the clinically inapparent adrenal mass ("incidentaloma")
Grumbach, M. M., Biller, B. M. K., Braunstein, G. D., Campbell, K. K., Carney, J. A., Godley, P. A., Harris, E. L., Lee, J. K. T., Oertel, Y. C., Posner, M. C., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-5-200303040-00013 · Cited by 945
A Survey on Adrenal Incidentaloma in Italy
Mantero, F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.637 · Cited by 907
Pathologic features of prognostic significance in adrenocortical carcinoma
Weiss, L. M., Medeiros, L. J., & Vickery, A. L. (1989) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198903000-00004 · Cited by 818
The clinically inapparent adrenal mass: update in diagnosis and management
Mansmann, G., Lau, J., Balk, E., Rothberg, M., Miyachi, Y., & Bornstein, S. R. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0031 · Cited by 781
Adrenocortical Carcinoma: Clinical Update
Allolio, B., & Fassnacht, M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2639 · Cited by 775
Self-citationAdjuvant Mitotane Treatment for Adrenocortical Carcinoma
Terzolo, M., Angeli, A., Faßnacht, M., Daffara, F., Tauchmanovà, L., Conton, P. A., Rossetto, R., Buci, L., Sperone, P., Grossrubatscher, E. M., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063360 · Cited by 759
Self-citationLuton, J.-P., Cerdas, S., Billaud, L., Thomas, G., Guilhaume, B., Bertagna, X., Laudat, M.-H., Louvel, A., Chapuis, Y., Blondeau, P., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199004263221705 · Cited by 717
Prevalence of adrenal incidentaloma in a contemporary computerized tomography series
Bovio, S., Cataldi, A., Reimondo, G., Sperone, P., Novello, S., Berruti, A., Borasio, P., Fava, C., Dogliotti, L., Scagliotti, G. V., et al. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03344099 · Cited by 712
Fassnacht, M., Johanssen, S., Quinkler, M., Bucsky, P., Willenberg, H. S., Beuschlein, F., Terzolo, M., Mueller, H., Hahner, S., Allolio, B., et al. (2009) · Cancer · doi:10.1002/cncr.24030 · Cited by 695
Self-citationCharacterization of adrenal masses using unenhanced CT: an analysis of the CT literature
Boland, G. W., Lee, M. J., Gazelle, G. S., Halpern, E. F., McNicholas, M. M., & Mueller, P. R. (1998) · American Journal of Roentgenology · doi:10.2214/ajr.171.1.9648789 · Cited by 693
Adrenal Masses: Characterization with Combined Unenhanced and Delayed Enhanced CT
Caoili, E. M., KOROBKIN, M. T., Francis, I. R., Cohan, R. H., Platt, J. F., Dunnick, N. R., & Raghupathi, K. I. (2002) · Radiology · doi:10.1148/radiol.2223010766 · Cited by 684
Song, J. H., Chaudhry, F. S., & Mayo-Smith, W. W. (2008) · American Journal of Roentgenology · doi:10.2214/ajr.07.2799 · Cited by 579
Icard, P., Goudet, P., Charpenay, C., Andreassian, B., Carnaille, B., Chapuis, Y., Cougard, P., Henry, J., & Proye, C. (2001) · World Journal of Surgery · doi:10.1007/s00268-001-0047-y · Cited by 543
Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress?
Kebebew, E., Reiff, E., Duh, Q., Clark, O. H., & McMillan, A. (2006) · World Journal of Surgery · doi:10.1007/s00268-005-0329-x · Cited by 451
Abiven, G., Coste, J., Groussin, L., Anract, P., Tissier, F., Legmann, P., Dousset, B., Bertagna, X., & Bertherat, J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2730 · Cited by 435
Management of patients with adrenal cancer: recommendations of an international consensus conference
Schteingart, D. E., Doherty, G. M., Gauger, P. G., Giordano, T. J., Hammer, G. D., Korobkin, M., & Worden, F. P. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.01029 · Cited by 421
Peña, C. S., Boland, G. W. L., Hahn, P. F., Lee, M. J., & Mueller, P. R. (2000) · Radiology · doi:10.1148/radiology.217.3.r00dc29798 · Cited by 399
Dackiw, A. P. B., Lee, J. E., Gagel, R. F., & Evans, D. B. (2001) · World Journal of Surgery · doi:10.1007/s00268-001-0030-7 · Cited by 390
Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis
Giordano, T. J., Thomas, D. G., Kuick, R., Lizyness, M., Misek, D. E., Smith, A. L., Sanders, D., Aljundi, R. T., Gauger, P. G., Thompson, N. W., et al. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63846-1 · Cited by 383
An eleven-year experience with adrenocortical carcinoma.
Pommier, R. F., & Brennan, M. F. (1992) · PubMed · Cited by 332
Haak, H. R., Hermans, J., van de Velde, C., Lentjes, E. G. W. M., Goslings, B. M., Fleuren, G. J., & Krans, H. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.183 · Cited by 329
Hough (1979) · doi:10.1093/ajcp/72.3.390 · Cited by 320
Szolar, D. H., Korobkin, M., Reittner, P., Berghold, A., Bauernhofer, T., Trummer, H., Schoellnast, H., Preidler, K. W., & Samonigg, H. (2005) · Radiology · doi:10.1148/radiol.2342031876 · Cited by 314
Adrenocortical Carcinoma: Clinical, Morphologic, and Molecular Characterization
Stojadinovic, A., Ghossein, R. A., Hoos, A., Nissan, A., Marshall, D., Dudas, M. E., Cordon‐Cardo, C., Jaques, D. P., & Brennan, M. F. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.4.941 · Cited by 312
Berruti, A., Terzolo, M., Sperone, P., Pia, A. R., Casa, S. D., Gross, D. J., Carnaghi, C., Casali, P. G., Porpiglia, F., Mantero, F., et al. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.01025 · Cited by 308
Radiofrequency Thermal Ablation of Abdominal Tumors: Lessons Learned from Complications
Rhim, H., Dodd, G. D., Chintapalli, K. N., Wood, B. J., Dupuy, D. E., Hvizda, J. L., Sewell, P. E., & Goldberg, S. N. (2004) · Radiographics · doi:10.1148/rg.241025144 · Cited by 304
Adrenal adenomas: relationship between histologic lipid and CT and MR findings.
KOROBKIN, M. T., Giordano, T. J., Brodeur, F. J., Francis, I. R., Siegelman, E. S., Quint, L. E., Dunnick, N. R., Heiken, J. P., & Wang, H. H. (1996) · Radiology · doi:10.1148/radiology.200.3.8756925 · Cited by 304
18F-FDG PET/CT in the evaluation of adrenal masses.
Metser, U., Miller, E., Lerman, H., Lievshitz, G., Avital, S., & Even‐Sapir, E. (2006) · PubMed · Cited by 296
Brix, D., Allolio, B., Fenske, W., Agha, A., Dralle, H., Jurowich, C., Langer, P., Mussack, T., Nies, C., Riedmiller, H., et al. (2010) · European Urology · doi:10.1016/j.eururo.2010.06.024 · Cited by 286
Self-citationAdrenocortical cancer: pathophysiology and clinical management
Libé, R., Fratticci, A., & Bertherat, J. Y. (2007) · Endocrine Related Cancer · doi:10.1677/erc.1.01130 · Cited by 271
Macfarlane, D. A. (1958) · PubMed · Cited by 266
The optimal imaging of adrenal tumours: a comparison of different methods
Ilias, Ι., Sahdev, A., Reznek, R. H., Grossman, A. B., & Pacák, K. (2007) · Endocrine Related Cancer · doi:10.1677/erc-07-0045 · Cited by 266
Hamrahian, A. H., Ioachimescu, A. G., Remer, E. M., Motta-Ramírez, G. A., Bogabathina, H., Levin, H. S., Reddy, S. S. K., Gill, I. S., SIPERSTEIN, A. E., & Bravo, E. L. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1627 · Cited by 264
Radiofrequency ablation of adrenal tumors and adrenocortical carcinoma metastases
Wood, B. J., Abraham, J., Hvizda, J. L., Alexander, H. R., & Fojo, T. (2003) · Cancer · doi:10.1002/cncr.11084 · Cited by 264
de Fraipont, F., El Atifi, M., Cherradi, N., Le Moigne, G., Defaye, G., Houlgatte, R., Bertherat, J., Bertagna, X., Plouin, P.-F., Baudin, E., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1075 · Cited by 261
Efficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma
Fassnacht, M., Hahner, S., Polat, B., Koschker, A.-C., Kenn, W., Flentje, M., & Allolio, B. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1007 · Cited by 259
Self-citationSullan, M., Boileau, M. A., & Hodges, C. V. (1978) · The Journal of Urology · doi:10.1016/s0022-5347(17)57317-6 · Cited by 255
Results of Laparoscopic Adrenalectomy for Suspected and Unsuspected Malignant Adrenal Neoplasms
Kebebew, E. (2002) · Archives of Surgery · doi:10.1001/archsurg.137.8.948 · Cited by 236
Prognostic parameters of metastatic adrenocortical carcinoma
Assié, G., Antoni, G., Tissier, F., Caillou, B., Abiven, G., Gicquel, C., Leboulleux, S., Travagli, J.-P., Dromain, C., Bertagna, X., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0706 · Cited by 236
Laparoscopic resection of adrenal cortical carcinoma: a cautionary note
Gonzalez, R. J., Shapiro, S., Sarlis, N., Vassilopoulou-Sellin, R., Perrier, N. D., Evans, D. B., & Lee, J. E. (2005) · Surgery · doi:10.1016/j.surg.2005.09.012 · Cited by 229
Laparoscopic resection is inappropriate in patients with known or suspected adrenocortical carcinoma
Miller, B. S., Ammori, J. B., Gauger, P. G., Broome, J. T., Hammer, G. D., & Doherty, G. M. (2010) · World Journal of Surgery · doi:10.1007/s00268-010-0532-2 · Cited by 221
Giovanni Lughezzani, A., Sun, M., Perrotte, P., Claudio Jeldres, A., Alasker, A., Hendrik Isbarn, A., Budäus, L., Shariat, S. F., Guazzoni, G. F., Montorsi, F., et al. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2009.12.007 · Cited by 214
Bellantone, R., Ferrante, A., Boscherini, M., Lombardi, C. P., Crucitti, P., Crucitti, F., Favia, G., Borrelli, D., Boffi, L., Capussotti, L., et al. (1997) · Surgery · doi:10.1016/s0039-6060(97)90229-4 · Cited by 210
Variation in the clinical courses of adult T-cell leukemia
Kawano, F., Yamaguchi, K., Nishimura, H., Tsuda, H., & Takatsuki, K. (1985) · Cancer · doi:10.1002/1097-0142(19850215)55:4 · Cited by 206
The Medical Treatment of Cushing's Syndrome
Miller, J. W., & Crapo, L. M. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-4-443 · Cited by 198
van Slooten, H., Moolenaar, A. J., van Seter, A. P., & Smeenk, D. (1984) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(84)90033-6 · Cited by 198
Radiotherapy in adrenocortical carcinoma
Polat, B., Fassnacht, M., Pfreundner, L., Guckenberger, M., Bratengeier, K., Johanssen, S., Kenn, W., Hahner, S., Allolio, B., & Flentje, M. (2009) · Cancer · doi:10.1002/cncr.24331 · Cited by 189
Self-citationPorpiglia, F., Fiori, C., Daffara, F., Zaggia, B., Bollito, E., Volante, M., Berruti, A., & Terzolo, M. (2010) · European Urology · doi:10.1016/j.eururo.2010.01.036 · Cited by 188
Khan, T. S., Imam, H., Juhlin, C. C., Skogseid, B. M., Gröndal, S., Tibblin, S., Wilander, E., Öberg, K., & Eriksson, B. (2000) · Annals of Oncology · doi:10.1023/a:1008377915129 · Cited by 183
Almeida, M. Q., Fragoso, M. C. B. V., Lotfi, C. F. P., Santos, M. G., Nishi, M. Y., Costa, M. H. S., Lerario, A. M., Maciel, C. C., Mattos, G. E., Jorge, A. A. L., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0065 · Cited by 176
Leboulleux, S., Dromain, C., Bonniaud, G., Auperin, A., Caillou, B., Lumbroso, J., Sigal, R., Baudin, É., & Schlumberger, M. J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1540 · Cited by 169
Molecular genetics of adrenocortical tumours, from familial to sporadic diseases
Libé, R., & Bertherat, J. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.02004 · Cited by 168
Sperone, P., Ferrero, A., Daffara, F., Priola, A. M., Zaggia, B., Volante, M., Santini, D., Vincenzi, B., Badalamenti, G., Intrivici, C., et al. (2010) · Endocrine Related Cancer · doi:10.1677/erc-09-0281 · Cited by 167
SCHULTE, H. M., BENKER, G., REINWEIN, D., SIPPELL, W. G., & ALLOLIO, B. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-5-1426 · Cited by 156
Self-citationMitotane for adrenocortical carcinoma treatment.
Hahner, S., & Faßnacht, M. (2005) · PubMed · Cited by 153
Treatment of Advanced Adrenocortical Carcinoma with Erlotinib plus Gemcitabine
Quinkler, M. O., Hahner, S., Wortmann, S., Johanssen, S., Adam, P., Ritte, C., Strasburger, C. J., Allolio, B., & Faßnacht, M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2564 · Cited by 149
Self-citationNorman, J., Lumley, J., Holdcroft, A., & Gaya, H. (1976) · The Lancet · doi:10.1016/s0140-6736(76)92884-1 · Cited by 145
MORIMOTO, R., SATOH, F., MURAKAMI, O., SUZUKI, T., ABE, T., TANEMOTO, M., ABE, M., URUNO, A., ISHIDOYA, S., ARAI, Y., et al. (2008) · Endocrine Journal · doi:10.1507/endocrj.k07-079 · Cited by 141
Adrenal tumors: How to establish malignancy?
Faßnacht, M., Kenn, W., & Allolio, B. (2004) · Journal of Endocrinological Investigation · doi:10.1007/bf03351068 · Cited by 141
Self-citationPark, B. K., Kim, C. K., Kim, B., & Lee, J. (2007) · Radiology · doi:10.1148/radiol.2433051978 · Cited by 141
Hennings, J., Lindhe, Ö., Bergström, M., Långström, B., Sundin, A., & Hellman, P. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2273 · Cited by 140
Mifepristone (RU 486) in Cushing's syndrome.
Johanssen, S., & Allolio, B. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0458 · Cited by 134
Self-citationSeccia, T. M., Fassina, A., Nussdorfer, G. G., Pessina, A. C., & Rossi, G. P. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.00867 · Cited by 131
Terzolo, M., Pia, A. R., Berruti, A., Osella, G., Alı̀, A., Carbone, V., Testa, E., Dogliotti, L., & Angeli, A. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.6.6619 · Cited by 116
Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms.
Goldblum, J. R., Shannon, R., Kaldjian, E. P., Thiny, M. T., Davenport, R. D., Thompson, N. W., & Lloyd, R. V. (1993) · PubMed · Cited by 116
Mackie, G. C., Shulkin, B. L., Ribeiro, R. C., Worden, F. P., Gauger, P. G., Mody, R. J., Connolly, L. P., Kunter, G., Rodriguez-Galindo, C., Wallis, J. W., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2612 · Cited by 115
DIAGNOSIS AND MANAGEMENT OF ADRENAL INCIDENTALOMAS
Barzon, L., & Boscaro, M. (2000) · The Journal of Urology · doi:10.1016/s0022-5347(05)67888-3 · Cited by 111
11C-Metomidate PET imaging of adrenocortical cancer
Khan, T. S., Sundin, A., Juhlin, C., Långström, B., Bergström, M., & Eriksson, B. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-1025-9 · Cited by 107
Emerging Treatment Strategies for Adrenocortical Carcinoma: A New Hope
Kirschner, L. S. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1739 · Cited by 107
Differentiating Adrenal Adenomas From Nonadenomas Using 18F-FDG PET/CT
Caoili, E. M., KOROBKIN, M. T., Brown, R. K. J., Mackie, G. C., & Shulkin, B. L. (2007) · Academic Radiology · doi:10.1016/j.acra.2007.01.009 · Cited by 102
ADRENOCORTICAL CARCINOMA WITH INTRACAVAL EXTENSION
Hedican, S. P., & Marshall, F. F. (1997) · The Journal of Urology · doi:10.1016/s0022-5347(01)68152-7 · Cited by 102
Adrenal cortical carcinoma in Norway, 1970–1984
Søreide, J. A., Brabrand, K., & Thoresen, S. (1992) · World Journal of Surgery · doi:10.1007/bf02067349 · Cited by 101
How accurate is MR imaging in characterisation of adrenal masses: update of a long-term study
Hönigschnabl, S., Gallo, S., Niederle, B., Prager, G., Kaserer, K., Lechner, G. L., & Heinz‐Peer, G. (2002) · European Journal of Radiology · doi:10.1016/s0720-048x(01)00443-0 · Cited by 98
Immunohistochemical assessment of Ki-67 in the differential diagnosis of adrenocortical tumors
Terzolo, M., Boccuzzi, A., Bovio, S., Cappia, S., Giuli, P. D., Alı̀, A., Paccotti, P., Porpiglia, F., Fontana, D., & Angeli, A. (2001) · Urology · doi:10.1016/s0090-4295(00)00852-9 · Cited by 96
[123I]Iodometomidate for molecular imaging of adrenocortical cytochrome P450 family 11B enzymes
Hahner, S., Stuermer, A., Kreissl, M., Reiners, C., Fassnacht, M., Haenscheid, H., Beuschlein, F., Zink, M., Lang, K., Allolio, B., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0050 · Cited by 95
Self-citationAdrenocortical Neoplasms: Role of Prognostic Markers MIB-1, P53, and RB
Vargas, M. P., Vargas, H. I., Kleiner, D. E., & Merino, M. J. (1997) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199705000-00008 · Cited by 89
Nader, N., Raverot, G., Emptoz-Bonneton, A., Déchaud, H., Bonnay, M., Baudin, E., & Pugeat, M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2157 · Cited by 89
Discerning malignancy in adrenocortical tumors: are molecular markers useful?
Wachenfeld, C., Beuschlein, F., Zwermann, O., Mora, P., Faßnacht, M., Allolio, B., & Reincke, M. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1450335 · Cited by 84
Self-citationAdrenocortical Carcinoma - Improving Patient Care by Establishing New Structures
Koschker, A., Faßnacht, M., Hahner, S., Weismann, D., & Allolio, B. (2006) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2006-923808 · Cited by 83
Self-citationSaeger, W., Faßnacht, M., Chita, R., Prager, G., Nies, C., Lorenz, K., Bärlehner, E., Simon, D., Niederle, B., Beuschlein, F., et al. (2003) · Human Pathology · doi:10.1053/hupa.2003.24 · Cited by 79
Self-citationDickstein, G., Shechner, C., Arad, E., Best, L., & Nativ, O. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.9.5113 · Cited by 74
Pathological and molecular features of adrenocortical carcinoma: an update
Volante, M., Buttigliero, C., Greco, E., Berruti, A., & Papotti, M. G. (2008) · Journal of Clinical Pathology · doi:10.1136/jcp.2007.050625 · Cited by 74
Adrenal Masses: Characterization with in Vivo Proton MR Spectroscopy—Initial Experience
Faria, J. F., Goldman, S. M., Szejnfeld, J., Melo, H. J. D. F. E., Kater, C. E., Kenney, P. J., Huayllas, M. K. P., Demarchi, G. T. S., Francisco, V. V., Andreoni, C., et al. (2007) · Radiology · doi:10.1148/radiol.2453061854 · Cited by 74
Schulick, R. D., & Brennan, M. F. (1999) · World Journal of Urology · doi:10.1007/s003450050101 · Cited by 73
Recent advances in histopathology and immunohistochemistry of adrenocortical carcinoma
Sasano, H., Suzuki, T., & Moriya, T. (2006) · Endocrine Pathology · doi:10.1007/s12022-006-0006-0 · Cited by 69
Concepts, Considerations, and Concerns on the Cutting Edge of Radiofrequency Ablation
Brown, D. B. (2005) · Journal of Vascular and Interventional Radiology · doi:10.1097/01.rvi.0000156097.63027.7b · Cited by 68
Cyclin E correlates with malignancy and adverse prognosis in adrenocortical tumors
Tissier, F., Louvel, A., Grabar, S., Hagnéré, A.-M., Bertherat, J. Y., Vacher‐Lavenu, M., Dousset, B. E., Chapuis, Y., BERTAGNA, X. Y., & Gicquel, C. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500809 · Cited by 54
Samnotra, V., Vassilopoulou‐Sellin, R., Fojo, A. T., Oh, W. K., Larocca, R. V., Ernstoff, M. S., Memoli, V. A., Cole, B. F., Quinn, D. I., Simmons, P., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.15527 · Cited by 53
New mechanisms of adrenostatic compounds in a human adrenocortical cancer cell line
Faßnacht, M., Hahner, S., Beuschlein, F., Klink, A., Reincke, M., & Allolio, B. (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.0300s3076.x · Cited by 52
Self-citationFaggiano, A., Leboulleux, S., Young, J., Schlumberger, M. J., & Baudin, É. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02403.x · Cited by 50
Analysis of adrenal masses by 18F-FDG positron emission tomography scanning
Han, S. ‐., Kim, T., Jeon, S.-H., Jeong, S. J., Yun, M., Rhee, Y., Kang, E. S., Cha, B.-S., Lee, E. J., Lee, H.-C., et al. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.01220.x · Cited by 49
Non-invasive evaluation of the incidentally detected indeterminate adrenal mass
Al-Hawary, M. M., Francis, I. R., & KOROBKIN, M. T. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2004.09.002 · Cited by 49
Terzolo, M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.6.2234 · Cited by 49
Sallah, S., Wan, J. Y., Nguyen, N. P., Vos, P. W., & Sigounas, G. (2001) · Cancer · doi:10.1002/1097-0142(20010915)92:6 · Cited by 47
Heinz‐Peer, G., Memarsadeghi, M., & Niederle, B. (2006) · Current Opinion in Urology · doi:10.1097/mou.0b013e328011ea00 · Cited by 44
Histopathological classification of adrenal tumours
Saeger, W. (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.0300s3058.x · Cited by 42
REGRESSION OF METASTATIC ADRENAL CARCINOMA DURING PALLIATIVE KETOCONAZOLE TREATMENT
Contreras, P. H. (1985) · The Lancet · doi:10.1016/s0140-6736(85)90251-x · Cited by 38
Scintigraphy of incidentally discovered bilateral adrenal masses
Gross, M. D., Shapiro, B., Francis, I. R., Bree, R. L., KOROBKIN, M. T., McLeod, M. K., Thompson, N. W., & SANFIELD, J. A. (1995) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/bf00941847 · Cited by 35
Recurrent adrenocortical carcinoma after laparoscopic resection
Schlamp, A., Hallfeldt, K. K. J., Müeller-Lisse, U. G., Pfluger, T., & Reincke, M. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0391 · Cited by 21
Dramatic Responses to Therapy in Rare Tumors
Chacon, R. D., Tossen, G., Loria, F. S., & Chacon, M. R. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.195 · Cited by 19
Billingsley, K. G., Maynard, C. C., Schwartz, D. L., & Dominitz, J. A. (2001) · Cancer · doi:10.1002/1097-0142(20010901)92:5 · Cited by 11
Venkatesh (1989) · doi:10.1002/1097-0142(19890801)64:3
Wooten (1993) · doi:10.1002/1097-0142(19931201)72:11
Wajchenberg (2000) · doi:10.1002/(sici)1097-0142(20000215)88:4
Flagged first, then by citations
2 of the 106 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Bergenstal, 1959, Regression of adrenal cancer and suppression of adrenal function in men by o,p-DDD, Transactions of American Physicians, 72, 341
Cited by
Sorted by citations
Fassnacht, M., Arlt, W., Bancos, I., Dralle, H., Newell-Price, J., Sahdev, A., Tabarin, A., Terzolo, M., Tsagarakis, S., & Dekkers, O. M. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0467 · Cited by 1,566
Faßnacht, M., Dekkers, O. M., Else, T., Baudin, É., Berruti, A., de Krijger, R. R., Haak, H. R., Mihai, R., Assié, G., & Terzolo, M. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0608 · Cited by 976
Else, T., Kim, A. C., Sabolch, A., Raymond, V. M., Kandathil, A., Caoili, E. M., Jolly, S., Miller, B. S., Giordano, T. J., & Hammer, G. D. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1029 · Cited by 892
Faßnacht, M., Tsagarakis, S., Terzolo, M., Tabarin, A., Sahdev, A., Newell-Price, J. D. C., Pelsma, I. C. M., Marina, L., Lorenz, K., Bancos, I., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad066 · Cited by 849
Adrenocortical carcinoma: a clinician’s update
Fassnacht, M., Libé, R., Kroiss, M., & Allolio, B. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.235 · Cited by 396
Self-citation
Metadata
- Authors
- Fassnacht, M., & Allolio, B.
- Affiliations
- University of Würzburg (DE)
- Corresponding author
- Fassnacht, Martin
- ORCID
- Fassnacht, Martin
- Venue
- Best Practice & Research Clinical Endocrinology & Metabolism
- Publisher
- Elsevier BV
- Published
- 2009-04
- Volume
- 23
- Issue
- 2
- Pages
- 273-289
- ISSN
- 1521-690X (ISSN-L)
- OpenAlex
- W2066923659
- Cited by
- 349
- References
- 106
- Citations by year
- 2026: 8 · 2025: 16 · 2024: 20 · 2023: 24 · 2022: 16 · 2021: 24 · 2020: 20 · 2019: 13 · 2018: 21 · 2017: 12 · 2016: 22 · 2015: 30 · 2014: 15 · 2013: 18 · 2012: 33
- FWCI
- 4.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Best Practice & Research Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Krebshilfe
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- adrenocortical carcinoma, adrenalectomy, cytotoxic chemotherapy, etoposide, doxorubicin, cisplatin, streptozotocin, targeted therapy, sunitinib, sorafenib, diagnostic workup, advanced disease
- MeSH terms
- Adrenal Cortex Hormones, Adrenal Cortex Neoplasms, Animals, Humans, Neoplasm Staging, Prognosis, Adrenocortical Carcinoma, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
